share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

SEC announcement ·  Apr 22 21:20
Summary by Futu AI
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.